Biocon Challenges Regeneron Over UK Retinal Pharma Patent
India's Biocon pharmaceutical group has sued Regeneron Pharmaceuticals, alleging that its medication to treat macular degeneration would not infringe Regeneron's patents, according to a High Court claim filed in London....To view the full article, register now.
Already a subscriber? Click here to view full article